136 related articles for article (PubMed ID: 1461535)
21. Management of cardiac complications in patients with thalassemia major.
Vecchio C; Derchi G
Semin Hematol; 1995 Oct; 32(4):288-96. PubMed ID: 8560286
[No Abstract] [Full Text] [Related]
22. [Non-pharmacological therapy of decompensated heart failure: the extracorporeal ultrafiltration].
Tovena DM; Pedrinazzi C; Ogliari V; De Petri G; Mileti M; Inama G
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):118S-122S. PubMed ID: 19195319
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of persistent cardiac failure by ultrafiltration].
Dussarat GV; Dalger J; Chateau J; Saissy JM; Talard P
Ann Cardiol Angeiol (Paris); 1989 Apr; 38(4):231-5. PubMed ID: 2735736
[TBL] [Abstract][Full Text] [Related]
24. [Management of advanced chronic heart failure].
Oliva F; Macera F; Verde A; Frigerio M
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):112S-117S. PubMed ID: 19195318
[TBL] [Abstract][Full Text] [Related]
25. Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure.
Paterna S; Parrinello G; Amato P; Dominguez L; Pinto A; Maniscalchi T; Cardinale A; Licata A; Amato V; Licata G; Di Pasquale P
Adv Ther; 1999; 16(5):219-28. PubMed ID: 10915397
[TBL] [Abstract][Full Text] [Related]
26. Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up.
Arbustini E; Gavazzi A; Dal Bello B; Morbini P; Campana C; Diegoli M; Grasso M; Fasani R; Banchieri N; Porcu E; Pilotto A; Ponzetta M; Bellini O; Lucreziotti S; Viganò M
G Ital Cardiol; 1997 Mar; 27(3):209-23. PubMed ID: 9199949
[TBL] [Abstract][Full Text] [Related]
27. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
28. A review of heart failure treatment.
Guyatt GH; Devereaux PJ
Mt Sinai J Med; 2004 Jan; 71(1):47-54. PubMed ID: 14770250
[TBL] [Abstract][Full Text] [Related]
29. Cardiac failure: mechanical support strategies.
Boehmer JP; Popjes E
Crit Care Med; 2006 Sep; 34(9 Suppl):S268-77. PubMed ID: 16917432
[TBL] [Abstract][Full Text] [Related]
30. [Long-term sustained low efficiency dialysis in eight patients with class IV NYHA heart failure resistant to high-dose diuretic treatment].
Violi F; Nacca RG; Iengo G; Iorio L
G Ital Nefrol; 2009; 26 Suppl 46():50-2. PubMed ID: 19644818
[TBL] [Abstract][Full Text] [Related]
31. [Body water compartments of patients with chronic heart failure and the refractory edema syndrome].
Aĭdargalieva NE; Sharashidze ML; Mareev VIu; Suvorov IuI; Kaplan MA
Ter Arkh; 1987; 59(9):78-81. PubMed ID: 3424195
[TBL] [Abstract][Full Text] [Related]
32. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
[TBL] [Abstract][Full Text] [Related]
33. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
Ramahi TM; Lee FA
Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
[TBL] [Abstract][Full Text] [Related]
34. [Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].
Fonseca C; Gouveia R; Ceia F; Mota E; Coelho EM; Gil V; Riva E; Astorga MA; Gomes RS; Luís AS
Rev Port Cardiol; 1992 Jun; 11(6):515-23. PubMed ID: 1503784
[TBL] [Abstract][Full Text] [Related]
35. Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
Bergler-Klein J; Sochor H; Pouleur H; Pacher R; Porenta G; Glogar D
J Cardiovasc Pharmacol; 1994 Aug; 24(2):194-8. PubMed ID: 7526050
[TBL] [Abstract][Full Text] [Related]
36. [Peritoneal dialyisis role in heart failure treatment, experience in our center].
Díez Ojea B; Rodríguez Suárez C; Vidau P; Gago E; Díaz Molina B; Martín Fernández M; García Cueto C
Nefrologia; 2007; 27(5):605-11. PubMed ID: 18045037
[TBL] [Abstract][Full Text] [Related]
37. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
[TBL] [Abstract][Full Text] [Related]
38. [Drug therapy of heart failure].
Follath F
Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
[TBL] [Abstract][Full Text] [Related]
39. Intermittent infusion of inotropes in the outpatient setting: one-year post treatment analysis.
López-Candales A; Carron C; Graham S; Schwartz J
P R Health Sci J; 2000 Jun; 19(2):107-14. PubMed ID: 10909705
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacotherapy of chronic heart failure].
Hoppe UC
Z Arztl Fortbild Qualitatssich; 2003 Apr; 97(2):113-9. PubMed ID: 12806816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
